Remove 2029 Remove Acquisitions Remove Securities
article thumbnail

HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities

Global Newswire by Notified: M&A

This strategic acquisition grants HYTN exclusive access to Prism’s suite of intellectual property, including, most significantly, its license (“ License ”) with respect to the technologies of Lux Sit Systems Inc.